LHC Group, Inc. (NASDAQ:LHCG) CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction on Monday, December 3rd. The stock was sold at an average price of $103.40, for a total value of $7,755,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this link.
LHCG stock opened at $104.83 on Thursday. The stock has a market capitalization of $3.29 billion, a P/E ratio of 43.32, a P/E/G ratio of 1.76 and a beta of 0.78. LHC Group, Inc. has a 52 week low of $58.65 and a 52 week high of $107.51. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.61 and a quick ratio of 1.61.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, October 31st. The health services provider reported $0.95 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.95. The business had revenue of $507.00 million during the quarter, compared to the consensus estimate of $515.03 million. LHC Group had a return on equity of 8.23% and a net margin of 3.85%. LHC Group’s revenue for the quarter was up 88.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.64 earnings per share. On average, sell-side analysts predict that LHC Group, Inc. will post 3.52 earnings per share for the current fiscal year.
LHCG has been the subject of a number of research reports. BidaskClub raised LHC Group from a “buy” rating to a “strong-buy” rating in a report on Friday, September 28th. UBS Group initiated coverage on LHC Group in a report on Thursday, November 15th. They set a “buy” rating and a $109.00 target price for the company. Zacks Investment Research raised LHC Group from a “hold” rating to a “buy” rating and set a $106.00 target price for the company in a report on Tuesday, November 6th. Robert W. Baird lifted their target price on LHC Group from $95.00 to $98.00 and gave the stock a “neutral” rating in a report on Friday, November 2nd. Finally, Craig Hallum downgraded LHC Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from $99.00 to $92.00 in a report on Friday, October 26th. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $105.92.
A number of hedge funds have recently bought and sold shares of the stock. BlackRock Inc. raised its stake in LHC Group by 76.9% in the second quarter. BlackRock Inc. now owns 4,619,436 shares of the health services provider’s stock valued at $395,377,000 after purchasing an additional 2,008,433 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in LHC Group by 74.6% in the second quarter. Dimensional Fund Advisors LP now owns 2,133,200 shares of the health services provider’s stock valued at $182,581,000 after purchasing an additional 911,625 shares in the last quarter. FMR LLC raised its stake in LHC Group by 297.8% in the second quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock valued at $98,548,000 after purchasing an additional 861,952 shares in the last quarter. Bank of New York Mellon Corp raised its stake in LHC Group by 2.9% in the third quarter. Bank of New York Mellon Corp now owns 732,075 shares of the health services provider’s stock valued at $75,394,000 after purchasing an additional 20,567 shares in the last quarter. Finally, Northern Trust Corp raised its stake in LHC Group by 51.7% in the second quarter. Northern Trust Corp now owns 572,094 shares of the health services provider’s stock valued at $48,966,000 after purchasing an additional 194,902 shares in the last quarter. 87.82% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “Keith G. Myers Sells 75,000 Shares of LHC Group, Inc. (LHCG) Stock” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/12/06/keith-g-myers-sells-75000-shares-of-lhc-group-inc-lhcg-stock.html.
About LHC Group
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
See Also: Leveraged Buyout (LBO)
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.